期刊文献+

疏水改性白及多糖自组装载紫杉醇纳米粒子在大鼠体内药动学研究

Pharmacokinetics of paclitaxel loaded nanoparticles made with hydrophobically modified Rhizoma Bletillae polysaccharide in rats
下载PDF
导出
摘要 目的建立一种简便、灵敏的测定大鼠尾静脉和灌胃给予胆甾醇琥珀酰基白及多糖载紫杉醇纳米粒子后的血浆药物浓度的HPLC方法,并评价其药动学特征。方法以酮康唑为内标,采用Agilent TC-C18色谱柱(250 mm×4.6 mm,5μm),以甲醇-乙腈-水(45∶20∶35)为流动相,流速为1.0 ml/min,采用统计矩法计算药动学参数,评价药动学特征。结果紫杉醇在大鼠血中浓度在0.5~20μg/ml范围内线性关系良好(r=0.999 7),准确度和精密度均符合生物样品分析要求。尾静脉注射3种不同取代度的自制纳米粒和紫杉醇注射液后的t1/2分别为3.86、3.76、3.35和2.62 h;灌胃给予自制紫杉醇纳米粒溶液和紫杉醇混悬液后的t1/2分别为5.28和3.72 h。结论该测定方法可用于紫杉醇纳米粒子在大鼠体内的药动学研究,且载紫杉醇自组装纳米粒子在体内的滞留时间比紫杉醇注射液和紫杉醇混悬液有明显延长。 Objective To establish a simple and sensitive method for the determination of plasma drug concentration in rats after intragastrical and intravenous administration of paclitaxel loaded nanoparticles and to evaluate its pharmacokinetic characteristics.Methods Agilent TC-C18 column( 250 mm × 4. 6 mm,5 μm) was used for HPLC at the flow rate 1 ml/min with ketoconazole as internal standard and methanol acetonitrile water( 45∶ 20∶ 35) as the mobile phase. The statistical moment method was applied to calculate the pharmacokinetic parameters and to evaluate pharmacokinetic characteristics. Results There was a good liner relationship( r =0. 999 7) when rat blood concentration of Paclitaxel ranged from 0. 5 to 20 μg/ml. The accuracy and precision were in line with the requirements of biological sample analysis. The t1/2 were 3. 86,3. 76,3. 35 and 2. 62 h after intravenous injection of three lab-made paclitaxel nanoparticles and paclitaxel solution via rat tail vein. The t1/2 were 5. 28 and 3. 72 h respectively after intragastrical administration of lab-made paclitaxel nanoparticles and paclitaxel suspension. Conclusion This method can be used for the pharmacokinetic study of paclitaxel nanoparticles in rats. The paclitaxel loaded nanoparticles exhibited significantly longer in vivo retention time than paclitaxel injection and paclitaxel suspension.
作者 张琦 赵文萃 刘洋 张公良 成念 侯吉华 ZHANG Qi;ZHAO Wencui;LIU Yang;ZHANG Gongliang;CHENG Nian;HOU Jihua(Jiangxi University of TCM , Nanchang 330004 , China;No .208 Hospital of PLA ,Changchun 130062 ,China;Changchun Cadres's Sanatorium ,Chang-chun 130052 ,China;Yanbian University ,Yanji 133000 ,China)
出处 《药学实践杂志》 CAS 2017年第6期504-507,共4页 Journal of Pharmaceutical Practice
基金 国家自然科学基金(81173559) 吉林省卫生计生委基金(2015ZC040)
关键词 白及多糖 紫杉醇 纳米粒子 药动学 Rhizoma Bletillae polysaccharide paclitaxel nanoparticles pharmacokinetics
  • 相关文献

参考文献10

二级参考文献126

  • 1[1]Rowinsky EK,Donehower RC.Paclitaxel (taxol) N Engl J Med 1995; 332:1004-1014 被引量:1
  • 2[2]Chang YF,Li LL,Wu CW,Liu TY,Lui WY,P'eng FK,Chi CW.Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.Cancer 1996; 77:14-18 被引量:1
  • 3[3]Kim YH,Shin SW,Kim BS,Kim JH,Kim JG,Mok YJ,Kim CS,Rhyu HS,Hyun JH,Kim JS.Paclitaxel,5-fluorouracil,and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.Cancer 1999; 85:295-301 被引量:1
  • 4[4]Murad AM,Petroianu A,Guimaraes RC,Aragao BC,Cabral LO,Scalabrini-Neto AO.Phase Ⅱ trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer:a novel,safe,and effective regimen.Am J Clin Oncol 1999; 22:580-586 被引量:1
  • 5[5]Lokich JJ,Sonneborn H,Anderson NR,Bern MM,Coco FV,Dow E,Oliynyk P.Combined paclitaxel,cisplatin,and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.Cancer 1999; 85:2347-2351 被引量:1
  • 6[6]Kollmannsberger C,Quietzsch D,Haag C,Lingenfelser T,Schroeder M,Hartmann JT,Baronius W,Hempel V,Clemens M,Kanz L,Bokemeyer C.A phase Ⅱ study of paclitaxel,weekly,24-hour continous infusion 5-fluorouracil,folinic acid and cisplatin in patients with advanced gastric cancer.Br J Cancer 2000; 83:458-462 被引量:1
  • 7[7]Garcia AA,Leichman CG,Lenz HJ,Baranda J,Lujan R,Casagrande Y,Leichman L.Phase Ⅱ trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic,measurable adenocarcinoma of the stomach.Jpn J Clin Oncol 2001; 31:275-278 被引量:1
  • 8[8]Yamada Y,Shirao K,Ohtsu A,Boku N,Hyodo I,Saitoh H,Miyata Y,Taguchi T.Phase Ⅱ trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions.Ann Oncol 2001; 12:1133-1137 被引量:1
  • 9[9]Wiernik PH,Schwartz EL,Einzig A,Strauman JJ,Lipton RB,Dutcher JP.Phase Ⅰ trial of taxol given as a 24-hour infusion every 21 days:responses observed in metastatic melanoma.J Clin Oncol 1987; 5:1232-1239 被引量:1
  • 10[10]Los G,Mutsaers PH,van der Vijgh WJ,Baldew GS,de Graaf PW,McVie JG.Direct diffusion of cis-diamminedichloroplatinum (Ⅱ) in intraperitoneal rat tumors after intraperitoneal chemotherapy:a comparison with systemic chemotherapy.Cancer Res 1989; 49:3380-3384 被引量:1

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部